NAYA Biosciences Net Income/Loss 2010-2024 | IVF
NAYA Biosciences net income/loss from 2010 to 2024. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
NAYA Biosciences Annual Net Income/Loss
(Millions of US $) |
| 2024 |
$-9 |
| 2023 |
$-8 |
| 2022 |
$-11 |
| 2021 |
$-7 |
| 2020 |
$-8 |
| 2019 |
$-2 |
| 2018 |
$-3 |
| 2017 |
$-1 |
| 2016 |
$-2 |
| 2015 |
$-5 |
| 2014 |
$-2 |
| 2013 |
$-1 |
| 2012 |
$-1 |
| 2011 |
$-1 |
| 2010 |
$0 |
| 2009 |
$-5 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.001B |
$0.007B |
|
NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.
|
